1,3-Butadiene and two major genotoxic metabolites 3,4-epoxybutene (EB) and 1,2:3,4-diepoxybutane (DEB) were used as model compounds to determine if genetic toxicity findings in animal and human cells can aid in extrapolating animal toxicity data to man. Sister chromatid exchange (SCE) and micronucleus induction results indicated 1,3-butadiene was genotoxic in the bone marrow of the mouse but not the rat. This paralleled the chronic bioassays which showed mice to be more susceptible than rats to 1,3-butadiene carcinogenicity. However, 1,3-butadiene did not induce unscheduled DNA synthesis (UDS) in the rat or mouse hepatocytes following in vivo exposure. Likewise, UDS in rat and mouse hepatocytes in vitro was not induced by EB or DEB. Salmonella typhimurium gene mutation (Ames) tests of 1,3-butadiene using strains TA1535, TA97, TA98, and TA100 and employing rat, mouse, and human liver S9 metabolic systems were barely 2-fold above background only in strain TA1535 at 30%o 1,3-butadiene in air with induced and uninduced rat S9 and mouse S9 (uninduced). 1,3-Butadiene was negative in in vitro SCE studies in human whole blood lymphocytes cultures treated in the presence of rat, mouse, or human liver S9 metabolic activation. In general, 1,3-butadiene is genotoxic in vivo but is a weak in vitro genotoxin.
Introduction
1,3-Butadiene is a potent carcinogen in B6C3F1 mice (1,2) but only weakly tumorigenic in Sprague-Dawley rats (3). These differences in carcinogenic potency have raised the question as to which of the two species, if either, is the better indicator of the human response. Studies evaluating the mutagenic response to 1,3-butadiene in vivo and in vitro in rodents and humans should permit a more quantitative estimation of toxicological differences between man and rodents. We examined the possibility that the genotoxicity of 1,3-butadiene or genotoxic metabolites is a major contributing factor to its carcinogenic activity in rodents.
Two known genotoxic metabolites, 3,4-epoxybutene (EB) and 1,2:3,4-epoxybutane (DEB) are formed in vivo (4) and in vitro (5, 6) and both bind covalently to DNA (7) (8) (9) . 3,4-Epoxybutene was reported to be genotoxic in Klebsiella and Salmonella (10) and induce sister chromatid exchange and chromosome aberrations in mice (11, 12) . DEB was also genotoxic in a variety of prokaryotic and eukaryotic organisms in vitro (13) (14) (15) (16) (17) .
1,3-Butadiene has been shown to be genotoxic in the Salmonella mutation assay (18) (19) (20) and in vivo in mice (21) (22) (23) ; it is, however, negative in rats (21) . Since 1,3-butadiene must be metabolized to exhibit genotoxicity (19), the metabolic competence of different species may determine the putative hazard in that species. Preliminary findings indicated that mouse liver homogenates are more active in producing EB than corresponding rat or primate (including human) homogenates (24) . Similarly, mouse lung homogenates generate more metabolites than rat lung homogenates. Kreiling et al. (25) reported that the maximal metabolic elimination rate of 1,3-butadiene in the mouse is nearly twice that of the rat. Blood concentrations of EB were two to five times higher in 1,3-butadiene-treated B6C3F1 mice than Sprague-Dawley rats (4 bAbbreviations: NT, not tested; 2-AA, 2-aminoanthracene, 2 ,ug/ plate; NaAz, sodium azide, 2 ,ug/plate. investigated the capability of Aroclor 1254-induced rat, and uninduced rat, mouse, and human S9 to activate 1,3-butadiene into genotoxic metabolites as detected by the Salmonella mutation assay (26) using strains TA1535, TA97, TA98, and TA100. All S9 preparations were made according to the procedure of Ames et al. (26) . Design concentrations of 1,3-butadiene gas were metered into specially constructed treatment chambers holding the agar plates overlaid with the bacteria and activation system. Actual gas concentrations were determined by gas chromatographic analysis before and after the 48-hr exposure. Because 1,3-butadiene is explosive at concentrations between 2 to 12% in air, the lowest dose that could be tested safely was 30%. Different treatment chambers were used for each activation system and for the nonactivated treatment.
1,3-Butadiene induced revertants only in strain TA1535 (Table 1) . Mouse S9 showed slightly higher activity than the uninduced rat or human S9 at 30% 1,3-butadiene in air. At concentrations exceeding 30%, the number of revertants decreased in the presence of rat or mouse S9. Results from the human S9-activated treatments did not differ substantially from those of the nonactivated treatments. Aroclor 1254-induced rat S9 gave similar results as mouse S9 (uninduced). Since the response was weak, the S9 concentration was increased from 0.8 mg/plate to 4.0 mg/plate (Table 2) . Increasing the concentration of Aroclor 1254-induced rat S9 had no effect on the number ofrevertants; slightly more revertants were observed using 4.0 than 0.8 mg/plate of uninduced rat S9.
These Salmonella typhimurium results differ from de Meester's (19) in two ways. First, the level of mutagenic activity was substantially lower with induced rat S9 than reported by de Meester (19) . Second, we were able to detect a weak response in strain TA1535 with uninduced rat S9. Differences in 1,3-butadiene and S9 protein concentrations and strains TA1530 versus TA1535 are probably the source of this interlaboratory variation. Human whole blood lymphocytes were also used to investigate the ability of rat, mouse, and human S9 to activate 1,3-butadiene to genotoxic metabolites using SCE as the biological marker (27) . Design concentrations of 1,3-butadiene gas were metered into specially constructed treatment chambers holding the culture flasks. Actual gas concentrations were determined by gas chromatographic analysis.
The average generation time and mitotic index of the cultured cells were unaffected by 1,3-butadiene treatment in the presence of S9; although in the presence of 1,3-butadiene and mouse S9, cells were beginning to demonstrate a dose-responsive decrease in average generation time (data not shown).
No positive SCE or dose responses were observed with or without any of the activation systems at 25 to 100% 1,3-butadiene in nitrogen (Table 3 ). In contrast, both cyclophosmid and mitomycin C induced SCEs for activated and nonactivated treatments, respectively.
In Vivo/lIn Vitro Unscheduled DNA Synthesis and In Vitro Assays
In the in vivo/in vitro unscheduled DNA synthesis (UDS) assay (28) , two 1,3-butadiene exposure/sampling protocols were employed. Male Sprague-Dawley (Crl:CD BR) rats and B6C3F1 (B6C3F1/CrlBR) mice were exposed nose-only to either air or air containing 10,000 ppm 1,3-butadiene for a) 6 hr on day 1 followed by 3 hr on day 2; livers sampled 2 hr after the end of the second exposure, and b) 6 hr/day for 2 days; livers sampled 18 hr after the second exposure. [See Cunningham et al. (21) for inhalation conditions.] No UDS was evident in either species under those conditions (Table 4) .
In the UDS assay in rodent hepatocytes in vitro (29) , test concentrations of EB and DEB ranged from 5 to 1000 ppm in medium. Both metabolites were cytotoxic above 5 ppm, as evidenced by a decrease in nuclear and cytoplasmic grain counts. No cell survival was obtained at concentrations above 1000 ppm. Both EB and DEB failed to induce UDS in rat and mouse hepatocytes. Slight increases in the net nuclear grain counts were evident; however, they appear to be the result of DEBand EB-induced cytotoxicity, as evidenced by a significant drop in grain counts over the cytoplasm. Table 5 displays an example ofthe effect ofEB on rat hepatocyte cultures.
In Vivo Genotoxicity in Rodent Bone Marrow Male Sprague-Dawley rats and B6C3F1 mice were exposed to 1,3-butadiene by nose-only inhalation at con- 
